Evercore ISI analyst issues OUTPERFORM recommendation for BP on October 5, 2026 09:15AM ET. BP was trading at $44.79 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current analyst recommendations are : 23 - Buy, 20 - Hold, 2 - Sell recommendations .Historical Analyst RecommendationsLatest 10 recommendationsReport DateAnalyst CompanyActionPrevious GradeNew GradePrice when posted...
Raymond James analyst issues OUTPERFORM recommendation for DIS on October 5, 2026 09:21AM ET. The previous...
UBS analyst issues BUY recommendation for VTRS on October 5, 2026 09:42AM ET. The previous analyst...
Wells Fargo analyst issues OVERWEIGHT recommendation for UBER on October 5, 2026 09:44AM ET. The previous...
Michael Tyndall from HSBC issued a price target of $157.00 for TSLA on 2026-10-05 07:42:00.The adjusted...
Michael Tyndall from HSBC issued a price target of $157.00 for TSLA on 2026-10-05 07:42:00.The adjusted price target was set to $157.00.At the time of the announcement, TSLA was trading...
Manan Gosalia from Wells Fargo issued a price target of $102.00 for WFC on 2026-10-05 05:43:00.The adjusted price target was set to $102.00.At the time of the announcement, WFC was...
from Scotiabank issued a price target of $27.50 for CMCSA on 2026-10-02 13:51:42.The adjusted price target was set to $27.50.At the time of the announcement, CMCSA was trading at $21.7099.The...
Jay Sole from UBS issued a price target of $34.00 for NKE on 2026-10-02 13:42:03.The adjusted price target was set to $34.00.At the time of the announcement, NKE was trading...
Angie Storozynski from Seaport Global issued a price target of $56.00 for NEE on 2026-10-02 13:36:59.The adjusted price target was set to $56.00.At the time of the announcement, NEE was...
In the first quarter of 2025, the company faced revenue declines, largely due to Paxlovid, while operational expenses surged. Management is committed to enhancing R&D productivity and optimizing capital allocation,...
In a landscape of fluctuating markets and regulatory uncertainties, the company experienced a remarkable revenue surge, reaching $36,077 million. Despite operational challenges, net income stood at $7,713 million. Management emphasized...
In the bustling corridors of Merck, management reflects on a transformative quarter. With net income rising to 5,085 million, the company celebrates strategic wins in oncology and diabetes, driven by...
In 2025, the company embraced growth through increased research and development, despite rising operating expenses. A net income of $24,780 million marked a decline, reflecting challenges in a fluctuating market....
In the first quarter of 2025, the company experienced a 9% revenue growth, fueled by increased sales and services. Operating expenses rose, reflecting evolving cost structures, while net income showed...
IonQ has established itself as a leader in the burgeoning field of quantum computing, representing a stock with substantial upside potential. With its focus on developing quantum technology, IonQ appeals...
In an environment where tech giants are experiencing varying levels of market valuation, Micron Technology stands out as a beacon of growth potential even while trading below its sector average....
In the dynamic landscape of AI infrastructure, a pivotal assumption has started to unravel: the belief that limited computing resources will sustain high pricing. This premise is vital for investors...
In a landmark achievement for Microsoft's AI capabilities, the company's Copilot program has recently expanded to reach 30 million paid seats, signaling a robust demand for its integrated AI solutions....
As the AI infrastructure market continues to evolve, a crucial assumption underpinning the valuation of key players in this sector is starting to exhibit signs of strain: the belief that...
